SIGA Technologies, Inc. (NASDAQ:SIGA - Get Free Report) saw some unusual options trading activity on Wednesday. Stock traders purchased 1,200 call options on the company. This is an increase of approximately 1,438% compared to the average volume of 78 call options.
SIGA Technologies Stock Performance
SIGA stock traded up $0.20 during trading on Friday, hitting $5.63. 487,997 shares of the company's stock traded hands, compared to its average volume of 773,712. The business has a fifty day simple moving average of $5.76 and a 200 day simple moving average of $6.20. SIGA Technologies has a 52 week low of $4.95 and a 52 week high of $12.83. The stock has a market capitalization of $402.21 million, a price-to-earnings ratio of 4.69 and a beta of 1.03.
SIGA Technologies (NASDAQ:SIGA - Get Free Report) last released its quarterly earnings results on Tuesday, March 11th. The company reported $0.63 EPS for the quarter. The company had revenue of $81.40 million during the quarter. SIGA Technologies had a return on equity of 49.06% and a net margin of 49.33%. Research analysts forecast that SIGA Technologies will post 1.04 earnings per share for the current fiscal year.
SIGA Technologies Announces Dividend
The business also recently declared a special dividend, which will be paid on Thursday, May 15th. Investors of record on Tuesday, April 29th will be given a $0.60 dividend. The ex-dividend date is Tuesday, April 29th.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently bought and sold shares of the company. AltraVue Capital LLC lifted its holdings in shares of SIGA Technologies by 14.1% in the 4th quarter. AltraVue Capital LLC now owns 2,639,524 shares of the company's stock worth $15,864,000 after acquiring an additional 326,630 shares during the last quarter. Renaissance Technologies LLC raised its position in SIGA Technologies by 237.7% in the 4th quarter. Renaissance Technologies LLC now owns 417,436 shares of the company's stock worth $2,509,000 after purchasing an additional 293,836 shares during the period. Dimensional Fund Advisors LP lifted its stake in SIGA Technologies by 11.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 2,126,065 shares of the company's stock worth $12,777,000 after purchasing an additional 217,926 shares during the last quarter. Denali Advisors LLC boosted its position in shares of SIGA Technologies by 58.3% during the fourth quarter. Denali Advisors LLC now owns 378,544 shares of the company's stock valued at $2,275,000 after buying an additional 139,354 shares during the period. Finally, American Century Companies Inc. grew its stake in shares of SIGA Technologies by 9.9% during the fourth quarter. American Century Companies Inc. now owns 1,271,972 shares of the company's stock valued at $7,645,000 after buying an additional 114,270 shares during the last quarter. 55.40% of the stock is owned by hedge funds and other institutional investors.
SIGA Technologies Company Profile
(
Get Free Report)
SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.
Read More
Before you consider SIGA Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SIGA Technologies wasn't on the list.
While SIGA Technologies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.